Follow
Phillip G Durham
Phillip G Durham
Verified email at email.unc.edu
Title
Cited by
Cited by
Year
Controlled degradation of disulfide-based epoxy thermosets for extreme environments
LM Johnson, E Ledet, ND Huffman, SL Swarner, SD Shepherd, ...
Polymer 64, 84-92, 2015
972015
Inhaled drug treatment for tuberculosis: Past progress and future prospects
AJ Hickey, PG Durham, A Dharmadhikari, EA Nardell
Journal of Controlled Release 240, 127-134, 2016
842016
Inorganic nanoparticles and the microbiome
K Qiu, PG Durham, AC Anselmo
Nano Research 11, 4936-4954, 2018
562018
The role of particle physico-chemical properties in pulmonary drug delivery for tuberculosis therapy
NP Mortensen, P Durham, AJ Hickey
Journal of microencapsulation 31 (8), 785-795, 2014
522014
Spray dried aerosol particles of pyrazinoic acid salts for tuberculosis therapy
PG Durham, Y Zhang, N German, N Mortensen, J Dhillon, DA Mitchison, ...
Molecular Pharmaceutics 12 (8), 2574-2581, 2015
302015
Acoustic holograms for directing arbitrary cavitation patterns
J Kim, S Kasoji, PG Durham, PA Dayton
Applied Physics Letters 118 (5), 2021
262021
Particle uptake efficiency is significantly affected by type of capping agent and cell line
F Zhang, P Durham, CM Sayes, BLT Lau, ED Bruce
Journal of Applied Toxicology 35 (10), 1114-1121, 2015
242015
Harnessing ultrasound-stimulated phase change contrast agents to improve antibiotic efficacy against methicillin-resistant Staphylococcus aureus biofilms
PG Durham, AE Sidders, JE Beam, KM Kedziora, PA Dayton, BP Conlon, ...
Biofilm 3, 100049, 2021
232021
In vitro dry powder inhaler formulation performance considerations
S Ziffels, NL Bemelmans, PG Durham, AJ Hickey
Journal of controlled release 199, 45-52, 2015
212015
Applications of sub-micron low-boiling point phase change contrast agents for ultrasound imaging and therapy
PG Durham, PA Dayton
Current Opinion in Colloid & Interface Science 56, 101498, 2021
202021
A spray-dried combination of capreomycin and CPZEN-45 for inhaled tuberculosis therapy
RA Pitner, PG Durham, IE Stewart, SG Reed, GH Cassell, AJ Hickey, ...
Journal of pharmaceutical sciences 108 (10), 3302-3311, 2019
202019
A dry powder combination of pyrazinoic acid and its n-propyl ester for aerosol administration to animals
PG Durham, EF Young, MS Braunstein, JT Welch, AJ Hickey
International journal of pharmaceutics 514 (2), 384-391, 2016
182016
Efficacy of pyrazinoic acid dry powder aerosols in resolving necrotic and non-necrotic granulomas in a guinea pig model of tuberculosis
SA Montgomery, EF Young, PG Durham, KE Zulauf, L Rank, BK Miller, ...
PLoS One 13 (9), e0204495, 2018
132018
Disposable dosators for pulmonary insufflation of therapeutic agents to small animals
PG Durham, SN Hanif, LG Contreras, EF Young, MS Braunstein, ...
JoVE (Journal of Visualized Experiments), e55356, 2017
102017
Inhaled pyrazinoic acid esters for the treatment of tuberculosis
EF Young, E Perkowski, S Malik, JD Hayden, PG Durham, L Zhong, ...
Pharmaceutical research 33, 2495-2505, 2016
102016
Low-intensity focused ultrasound produces immune response in pancreatic cancer
JB Joiner, NP Kren, PG Durham, AJ McRee, PA Dayton, ...
Ultrasound in Medicine & Biology 48 (11), 2344-2353, 2022
82022
Magnetic resonance detection of gas microbubbles via hypercest: A path toward dual modality contrast agent
CT McHugh, PG Durham, M Kelley, PA Dayton, RT Branca
ChemPhysChem 22 (12), 1219-1228, 2021
62021
Low‐boiling Point Perfluorocarbon Nanodroplets as Dual‐Phase Dual‐Modality MR/US Contrast Agent
CT McHugh, PG Durham, S Atalla, M Kelley, NJ Bryden, PA Dayton, ...
ChemPhysChem 23 (24), e202200438, 2022
42022
Efficacy of inhaled CPZEN-45 in treating tuberculosis in the guinea pig
EF Young, PG Durham, EF Perkowski, S Malik, AJ Hickey, M Braunstein
Tuberculosis 135, 102207, 2022
42022
Overcoming biological barriers to improve treatment of a Staphylococcus aureus wound infection
V Papadopoulou, AE Sidders, KY Lu, AZ Velez, PG Durham, DT Bui, ...
Cell Chemical Biology 30 (5), 513-526. e5, 2023
32023
The system can't perform the operation now. Try again later.
Articles 1–20